Global Validation Regulations & Standards
GAMP 5 for Laboratory Systems: LIMS, CDS and Bioanalytical Platforms In the ever-evolving pharmaceutical and biotechnological landscapes, the regulatory expectations for validation of laboratory systems are critical. The use of automated systems such as Laboratory Information Management Systems (LIMS), Chromatography Data Systems (CDS), and bioanalytical platforms are governed by stringent guidelines laid out by international regulatory authorities. Among these, GAMP…
Using GAMP 5 to Strengthen Data Integrity Risk Assessments for GxP Systems Using GAMP 5 to Strengthen Data Integrity Risk Assessments for GxP Systems In today’s regulatory environment, ensuring data integrity in Good Practice (GxP) systems is paramount for pharmaceutical and biotechnology organizations. The challenges associated with GxP data integrity risk assessment can be effectively addressed using the GAMP 5…
End-to-End GxP System Lifecycle: From Concept to Retirement Under GAMP 5 End-to-End GxP System Lifecycle: From Concept to Retirement Under GAMP 5 Introduction to the GAMP 5 Lifecycle The Good Automated Manufacturing Practice (GAMP) 5 guidance provides a structured approach to the lifecycle of computerized systems used in regulated environments, particularly in the fields of pharmaceuticals and biotechnology. The GAMP…
US FDA vs EMA vs MHRA: Key Differences in Process Validation Expectations In the pharmaceutical industry, validation is a critical component that ensures processes, equipment, and systems operate as intended. Regulatory authorities worldwide, including the US FDA, EMA, and MHRA, set forth comprehensive guidelines that pharmaceutical companies must adhere to. This article serves as a detailed explainer manual providing a…
Validation Documentation Requirements for FDA, EMA and MHRA Inspections Introduction to Validation Documentation Expectations Validation is a critical aspect of pharmaceutical development and manufacturing, ensuring that processes and systems consistently produce products that meet quality standards. Understanding the validation documentation requirements across various regulatory agencies, including the US FDA, EMA, and MHRA, is essential for professionals in the pharmaceutical industry….
MHRA’s View on Data Integrity vs FDA and EMA: What Validation Teams Must Know Understanding data integrity within the pharmaceutical industry is imperative for compliance with regulatory expectations. This article provides a comprehensive overview of the MHRA’s approach to data integrity, especially when compared to the standards set by the FDA and EMA. By examining key regulatory documents and guidelines,…
Stability and Shelf Life Justification: Comparing US and EU Expectations Stability and Shelf Life Justification: Comparing US and EU Expectations The stability of pharmaceutical products is a critical aspect of ensuring their safety and efficacy throughout their shelf life. The regulatory expectations for stability validation can vary significantly between the United States and the European Union. This article examines the…
Global Validation Strategy: Harmonising US, EU and UK Requirements Across Sites Faced with complex regulatory landscapes, pharmaceutical organizations must develop a robust global validation strategy that harmonizes validation processes across multiple jurisdictions. This ensures compliance with the diverse regulatory frameworks of the US FDA, EU EMA, UK MHRA, and PIC/S. By understanding the expectations outlined by these regulatory bodies, organizations…
Validation and QRM: How FDA, EMA and MHRA Interpret ICH Q9 in Practice Validation and QRM: How FDA, EMA and MHRA Interpret ICH Q9 in Practice In the pharmaceutical industry, validation processes are critical to ensure product quality, safety, and efficacy. Regulatory agencies such as the US FDA, EMA, and MHRA emphasize the importance of validation through various guidelines and…
Annex 15 vs FDA Process Validation Guidance: Bridging Requirements Annex 15 vs FDA Process Validation Guidance: Bridging Requirements Introduction to Validation Practices in Pharmaceutical Manufacturing Validation is a critical component of the pharmaceutical manufacturing process, ensuring that products consistently meet quality standards. Regulatory authorities including the US FDA, EMA, and WHO provide guidelines to promote safety and efficacy in drug…